Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Translational Oncology|October 3, 2020
9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenograftsRaoud Marayati, Laura V Bownes, Laura L Stafman, et al.Translational Oncology|October 19, 2016
Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of RhabdomyosarcomaAlicia M Waters, Laura L Stafman, Evan F Garner, et al.Oncotarget|June 2, 2018
Targeting PIM kinase as a therapeutic strategy in human hepatoblastomaLaura L Stafman, Smitha Mruthyunjayappa, Alicia M Waters, et al.International Journal of Molecular Sciences|May 14, 2025
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of <i>TRIM29</i>Swatika Butey, Morgan L Brown, Janet R Julson, et al.The Journal of Surgical Research|March 7, 2018
Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminomaLaura L Stafman, Ilan I Maizlin, Matthew Dellinger, et al.Scientific Reports|March 17, 2021
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastomaRaoud Marayati, Laura L Stafman, Adele P Williams, et al.Cancer Gene Therapy|April 17, 2021
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cellsRaoud Marayati, Laura L Stafman, Adele P Williams, et al.Scientific Reports|September 15, 2019
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived XenograftsLaura L Stafman, Adele P Williams, Raoud Marayati, et al.Journal of Neuro-Oncology|August 23, 2018
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenograftsEvan F Garner, Laura L Stafman, Adele P Williams, et al.Plos One|March 10, 2021
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growthLaura V Bownes, Adele P Williams, Raoud Marayati, et al.Pageof 3